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1  | INTRODUC TION
The inappropriate use of antibiotics in medication and livestock, 
the anthropogenic release of natural and chemical biocides in ag‐
riculture, and the discharge of wastewater effluent containing bio‐
active residues to the environment, these altogether demonstrate 
the overuse of antimicrobial substances, which is a significant factor 
causing the antimicrobial resistance (AMR) crisis (Fiorentino et al., 
2019; Rodriguez‐Mozaz et al., 2015; Ventola, 2015). Moreover, ex‐
isting medicines are less efficient in the treatment of infectious dis‐
eases and have limitation for further developments of their modes of 
action, while the antimicrobial evolution of pathogens occurs more 
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Abstract
A way to defeat antimicrobial resistance (AMR) crisis is to supply novel drugs to the 
pharmaceutical industry. This effort leads to a global call for seeking the beneficial 
microbes from underexplored habitats. To support this call, we isolated Streptomyces 
sp. TM32 from the rhizosphere soil of a medicinal plant, turmeric (Curcuma longa L.). 
TM32 exhibited strong antimicrobial activities against both human and plant patho‐
gens, including an AMR pathogen, Staphylococcus haemolyticus MR‐CoNS. 
Surprisingly, such antimicrobial results of TM32's autoclaved crude extract remained 
the same. Based on the genome data analysis, TM32 belongs to the same genomic 
species with Streptomyces sioyaensis DSM 40032T, supported by the relatively high‐
average nucleotide identity values (ANIb: 96.80% and OrthoANIu: 97.14%) and in 
silico DNA–DNA relatedness value of 75.40%. Importantly, the gene annotation 
analyses revealed that TM32's genome contains various genes encoding the biosyn‐
thesis of either known or unknown antibiotics and some metabolites involved in plant 
growth‐promoting traits. However, bioactivities and genome data comparison of 
TM32 and DSM 40032T showed a set of apparent differences, for example, antimi‐
crobial potentials, genome size, number, and occurrence of coding DNA sequences in 
the chromosomes. These findings suggest that TM32 is a new strain of S. sioyaensis 
and serves as an emerging source for further discovery of valuable and novel bioac‐
tive compounds.
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rapidly (Piddock, 2012; Spellberg, Bartlett, & Gilbert, 2013). These 
critical concerns lead to a global call for encouraging the discovery 
of novel drugs that possess distinct molecular structures and offer 
broad‐spectrum functions, as a chance to defeat the AMR problem.
The best‐known natural sources for seeking bioactive com‐
pounds (eg, antibiotics, anticancer/antitumor agents, biocatalysts, 
etc.) are plants and microbes. For centuries, some herbs have served 
as natural medicines in the treatments of human diseases (Alvin, 
Miller, & Neilan, 2014; Strobel & Daisy, 2003). These plants synthe‐
size pharmaceutical metabolites that may be stored into their cells 
and tissues or released in the form of root exudates. Some microbes 
can live within or in contact with bioactive phytochemicals (Alvin et 
al., 2014; Nakaew & Sungthong, 2018; Strobel & Daisy, 2003), while 
some of which also enable to form the same or similar metabolites to 
those produced by plants (Alvin et al., 2014; Strobel & Daisy, 2003). 
These plant‐associated niches are yet a challenging source for the 
discovery of new microbial candidates and their novel secondary 
metabolites.
With the industrial point of view, antibiotic‐producing microbes 
require less space for cultivation, shorter time for biosynthesis, and 
offer higher flexibility in further biotechnological developments. 
Among the microbial producers, actinobacteria are well‐known cell 
factories for drug discovery, especially for those belonging to the 
genus Streptomyces (Bentley et al., 2002; Tiwari & Gupta, 2012). 
More than two‐thirds of all existing natural antibiotics derive from 
this actinobacterial genus (Bentley et al., 2002). Streptomyces is a 
well‐explored genus, which consists of 848 species and 38 sub‐
species, referring to the list of prokaryotic names with standing 
in nomenclature (http://www.bacterio.net/streptomyces.html) 
during the time of writing this article. Regarding these high num‐
bers of published Streptomyces members, the recent trend of drug 
discovery is more focusing on other microbial resources, such as 
non‐Streptomyces actinobacteria, so‐called “rare actinomycetes” 
with the aim to avoid the repetitive finding of the formerly found 
bioactive metabolites (Tiwari & Gupta, 2012). However, hitherto, it 
is just a minority of microbes discovered, while the majority of them 
is hidden in nature and waiting for exploration.
Streptomyces sp. TM32 was isolated based on the concept of 
plant–microbe interactions from the rhizosphere soil of turmeric 
(Curcuma longa L.), a rhizomatous and herbaceous plant, often used 
in cooking (Nakaew, Rangjaroen, & Sungthong, 2015). A preliminary 
identification of TM32 using its 16S rRNA gene sequence revealed 
the closest phylogenetic relation to Streptomyces sioyaensis DSM 
40032T, a producer of a peptide thiazole antibiotic, siomycin A, pos‐
sessing both antibacterial and anticancer functions (Gartel, 2013; 
Tori et al., 1979). TM32 showed strong antifungal activity and was 
proven for its plant growth‐promoting (PGP) potentials in the sup‐
pression of phytopathogenic fungus, Rigidoporus sp. (Nakaew et al., 
2015).
In this study, we aim to report some interesting bioactivities and 
the draft genomes of the type strain, S. sioyaensis DSM 40032T, and 
our emerging strain, TM32. We also unveil the biotechnological trea‐
sures in both genomes by employing some bioinformatics tools and 
discuss the novelty of TM32 based on a set of comparative genome 
data.
2  | MATERIAL S AND METHODS
The antimicrobial activities of crude extracts derived from DSM 
40032T (type strain) or TM32 were tested against either bacte‐
ria or fungi and some of which are pathogens of human and plant 
(Table 1). Each Streptomyces strain was grown in Hickey‐Tresner 
agar at 30°C for 7 days, which was transferred to grow further in 
200 ml of International Streptomyces Project medium II (ISP2) broth 
under shaking conditions at 150 rpm, 30°C for 14 days (Nakaew et 
al., 2015). The whole liquid culture was extracted with ethyl acetate 
at a solute and solvent ratio of 1:2 (v/v) for one night, in which the 
separated supernatant was collected and evaporated at 45°C using a 
rotary evaporator (Büchi, Switzerland). The crude extracts obtained 
TA B L E  1   Some antimicrobial activities of crude extracts derived from Streptomyces sioyaensis DSM 40032T and Streptomyces sp. TM32
Test microorganism
DSM 40032Ta  TM32a 
Crude extract Heated‐crude extract Crude extract Heated‐crude extract
Gram‐positive bacteria
Bacillus subtilis DMST 5871 + (8.0 ± 0.0) + (7.5 ± 0.7) + (8.0 ± 0.0) + (8.5 ± 0.7)
Staphylococcus aureus TISTR 
1466
+ (9.5 ± 0.7) + (10.0 ± 0.0) + (9.5 ± 0.7) + (10.0 ± 0.0)
Staphylococcus haemolyticus 
MR‐CoNS 102
− − + (8.0 ± 0.0) + (8.0 ± 0.0)
Gram‐negative bacteria
Escherichia coli TISTR 887 − − − −
Phytopathogenic fungi     
Alternaria alternata TISTR 3435 + (6.0 ± 0.0) + (2.0 ± 0.0) ++++ (37.5 ± 0.7) +++ (29.0 ± 1.4)
aThe	antimicrobial	activity	was	determined	into	five	levels	(excellent	++++,	very	good	+++,	good	++,	fair	+,	and	no	activity	−).	The	value	in	parenthesis	
refers to the average size (ø mm) ± standard deviation of the inhibitory zones derived from the duplicate antagonism assays. 
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were divided into two proportions and one of which was heated by 
autoclaving at 121°C, 15 psi for 15 min.
Both nonheated and heated crude extracts were dissolved 
with dimethyl sulfoxide (DMSO) and tested for their antimicrobial 
activities by the paper disk‐diffusion method described elsewhere 
(Nakaew, Sungthong, Ortega‐Calvo, & Lumyong, 2012). The over‐
night culture of test bacteria in nutrient broth (Himedia, India) and 
2‐day‐old culture of test fungi in potato dextrose broth (Himedia, 
India) were prepared by shaking incubation at 150 rpm and 30°C. 
The culture of each test microbe was swabbed over its correspond‐
ing agar medium mentioned before. Paper disks were pasted on the 
test agar medium, in which 30 μL of the crude extracts, 2 mg/ml na‐
lidixic acid (positive antibacterial), 1 mg/ml cycloheximide (positive 
antifungal), or DMSO (negative control) was dropped. The antimi‐
crobial activity was reported with the diameter size of the inhibitory 
zone appeared on the assayed plates.
The biomass of DSM 40032T or TM32 was prepared after 
cultivation in ISP2 broth under shaking conditions at 150 rpm, 
30°C for 5 days. Total genomic DNA of both strains was extracted 
and used for sequencing with the Illumina HiSeq2500 system, 
following the services provided by BaseClear BV (Leiden, the 
Netherlands). The reads generated from the sequencing were 
assembled using SPAdes version 3.9 (Bankevich et al., 2012) and 
evaluated by QUAST version 3.2 (Gurevich, Saveliev, Vyahhi, & 
Tesler, 2013). The gene annotation analysis was carried out based 
on all contigs of each genome using Prokka (Seemann, 2014). The 
secondary metabolite‐related genes and gene clusters present in 
the genomes were predicted using antiSMASH 3.0 (Weber et al., 
2015).
Identification of TM32 using its 16S rRNA gene sequence 
(GenBank accession no. KR534214) was performed using EzBioCloud 
database (https://www.ezbiocloud.net). The average nucleotide 
identity between the two genomes by BlastN (ANIb) and the orthol‐
ogous average nucleotide identity by USEARCH (OrthoANIu) were 
computed in JSpeciesWS (Richter, Rosselló‐Móra, Oliver Glöckner, & 
Peplies, 2015) and EzBioCloud (Yoon, Ha, Lim, Kwon, & Chun, 2017), 
respectively. DNA–DNA relatedness between the two genomes 
was evaluated by in silico DNA–DNA hybridization (DDH) (Meier‐
Kolthoff, Auch, Klenk, & Göker, 2013).
3  | RESULTS
The crude extracts provided by ethyl acetate extraction of both 
Streptomyces strains did not show antimicrobial activity against the 
test Gram‐negative bacterium, Escherichia coli TISTR 887 (Table 1). 
Surprisingly, their heated crude extracts by autoclaving at 121°C 
remained antimicrobial functions. DSM 40032T exhibited less 
antifungal activity than TM32 and did not inhibit a methicillin‐re‐
sistant coagulase negative pathogen, Staphylococcus haemolyticus 
MR‐CoNS 102 (Seng et al., 2017). The antifungal potential of DSM 
40032T's crude extracts was decreased by 67% when the extracts 
got heated before test, which was much higher compared to that of 
TM32 (23%). These findings highly prove that TM32 would serve 
as a promising source for further elucidations of valuable and novel 
antibiotics.
The sequencing generated 10,958,683 reads for DSM 40032T 
and 6,613,213 reads for TM32. The characteristics of both genomes 
are listed in Table 2. DSM 40032T has a genome size of 7,847,945 bp 
in 289 contigs with a G + C content of 71.60%, which is larger than 
the genome of TM32 (6,909,112 bp in 277 contigs with a G + C con‐
tent of 71.39%). There are 6,646 coding DNA sequences (CDSs) pre‐
dicted in the chromosome of DSM 40032T, including 74 tRNA and 4 
rRNA genes, while TM32's chromosome contains 6,072 CDSs with 
72 tRNA and 3 rRNA genes (Table 2).
Some CDSs of both genomes have relevance in PGP traits, 
that is, nitrogen assimilation, phosphate solubilization, iron se‐
questration, and productions of biocatalysts and phytohormones 
(Table 3). TM32 possesses an extra chitinase gene (chiD), which 
is absent in the chromosome of DSM 40032T. This finding may 
result in the stronger antifungal activity of TM32 compared to 
DSM 40032T (Table 1). However, TM32 lacks the exo‐β‐1,3‐glu‐
canase gene, which is present in DSM 40032T's chromosome. 
The absence of the glucanase gene was concordant to the pheno‐
type of TM32 previously observed by an in vitro enzymatic assay 
(Nakaew et al., 2015).
DSM 40032T has a higher number (45) of secondary metabo‐
lite‐related gene clusters than TM32 (29 gene clusters) (Table 4). 
Both strains have a siomycin‐encoding gene cluster in their ge‐
nomes, which is a unique characteristic of S. sioyaensis (Gartel, 
2013; Tori et al., 1979). DSM 40032T possesses a lot of micro‐
monolactam gene clusters (8), while TM32 does not have even 
one. The PGP‐related siderophore gene clusters are present in 
both genomes. Interestingly, there are many gene clusters of un‐
known secondary metabolites found in both genomes (indicated 
with <100% gene cluster similarity to the database), which should 
be elucidated later for their bioactivities, molecular structures, 
and biosynthetic pathways.
TA B L E  2   Genome characteristics of Streptomyces sioyaensis 
DSM 40032T and Streptomyces sp. TM32
Genome characteristic DSM 40032T TM32
Genome size (bp) 7,847,945 6,909,112
Number of contig 289 277
Largest contig (bp) 175,362 144,590
N50 (bp) 54,690 33,909
N75 (bp) 27,423 19,644
L50 41 58
L75 94 124
G + C content (%) 71.60 71.39
Number of   
Coding DNA sequence 6,646 6,072
rRNA gene 4 3
tRNA gene 74 72
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TA B L E  3   Some plant growth‐promoting gene clusters in the chromosomes of Streptomyces sioyaensis DSM 40032T and Streptomyces sp. TM32
Plant growth‐promoting trait Relevant gene and product COGa  DSM 40032Tb  TM32b 
Nitrogen assimilation nasD Nitrite reductase COG1251 + +
napA‐1 Nitrate reductase  + +
napA‐2 Nitrate reductase  + −
narK‐1 Nitrate/nitrite transporter COG2223 + +
narK‐2 Nitrate/nitrite transporter COG2223 + −
Phosphate solubilization gpm2‐1 Acid phosphatase COG0406 + +
gpm2‐2 Acid phosphatase COG0406 + +
phoD‐1 Alkaline phosphatase D COG3540 + +
phoD‐2 Alkaline phosphatase D COG3540 + −
phoP‐1 Alkaline phosphatase synthesis transcriptional regulatory protein COG0745 + +
phoP‐2 Alkaline phosphatase synthesis transcriptional regulatory protein COG0745 + +
phoP‐3 Alkaline phosphatase synthesis transcriptional regulatory protein COG0745 + −
sphR Alkaline phosphatase synthesis transcriptional regulatory protein COG0745 − +
ycdX Phosphatase  + +
 Putative phosphatase  + +
 Putative phosphatase COG0560 + −
Iron sequestration sbnA Putative siderophore biosynthesis protein COG0031 + +
yusV Putative siderophore transport system ATP‐binding protein COG1120 + +
yfhA Putative siderophore transport system permease protein COG0609 + +
yfiY Putative siderophore‐binding lipoprotein COG0614 + +
Biocatalyst acdS 1‐Aminocyclopropane‐1‐carboxylate deaminase  + +
aml α‐Amylase  + +
bca‐1 Bromoperoxidase‐catalase  + +
bca‐2 Bromoperoxidase‐catalase  + +
katA Catalase  + +
katG Catalase‐peroxidase  + +
cenA Endoglucanase A (endo‐β‐1,4‐glucanase) COG5297 + +
 Exo‐β‐1,3‐glucanase  + −
 Exochitinase 1  + −
chiA‐1 Putative bifunctional chitinase/lysozyme  + +
chiA‐2 Putative bifunctional chitinase/lysozyme  − +
chiC Chitinase C  + +
chiD Chitinase D  − +
 Lipase  + +
 Lipase 2  + +
lip3‐1 Lipase 3  + +
lip3‐2 Lipase 3  + +
 Thermostable monoacylglycerol lipase  + +
snpA Extracellular small neutral protease  + +
htpX‐1 Protease COG0501 + +
htpX‐2 Protease  + +
htpX‐3 Protease COG0501 + +
htpX‐4 Protease  + +
htpX‐5 Protease  + −
prtS Protease  + +
Phytohormone production trpC Indole‐3‐glycerol phosphate synthase COG0134 + +
aCOG refers to “Clusters of Orthologous Groups” in the Prokka pipeline (Seemann, 2014). bThe presence and absence of each gene cluster is deter‐
mined	by	+	and	−,	respectively.	
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TA B L E  4   Some gene clusters encoding secondary metabolite biosynthesis in the chromosomes of Streptomyces sioyaensis DSM 40032T 
and Streptomyces sp. TM32
Type of secondary metabolite Most similar known cluster MIBiG BGC‐IDa  DSM 40032Tb  TM32b 
Bacteriocin   + (3 clusters) + (3 clusters)
Butyrolactone Blasticidin BGC0000874 + (7%) + (7%)
Coelimycin BGC0000038 + (12%) −
Unknown  + (1 cluster) + (1 cluster)
Butyrolactone‐Phenazine‐other PKS Esmeraldin BGC0000935 + (64%) −
Ectoine Ectoine BGC0000853 + (100%) + (100%)
Ladderane Colabomycin BGC0000213 + (4%) + (4%)
Lanthipeptide Kanamycin BGC0000703 − + (1%)
Unknown  − + (1 cluster)
Lassopeptide Chaxapeptin BGC0001307 + (42%) + (42%)
FD‐594 BGC0000222 − + (4%)
Linaridin Legonaridin BGC0001188 + (55%) + (55%)
Unknown  + (1 cluster) −
Melanin A‐500359s BGC0000949 + (5%) −
Non‐ribosomal peptide synthase (NRPS) A‐503083 BGC0000288 + (7%) −
Lipstatin BGC0000382 + (28%) + (28%)
Neocarzilin BGC0000111 − + (14%)
Unknown  − + (1 cluster)
Polyketide synthase (PKS)
Type 1 PKS Hedamycin BGC0000233 + (6%) −
Maklamicin BGC0001288 + (13%) −
Micromonolactam BGC0000095 + (100%, 8 clusters) −
Phoslactomycin B BGC0000123 + (100%) −
Pladienolide BGC0000126 + (50%) −
PM100117/PM100118 BGC0001359 + (26%, 40%, 47%) −
Stambomycin  + (36%) −
Unknown BGC0000151 + (1 cluster) + (1 cluster)
Vicenistatin BGC0000167 + (25%, 60%) −
Type 2 PKS Lysolipin BGC0000242 − + (50%)
Spore pigment BGC0000271 + (75%) + (75%)
Type 3 PKS Naringenin BGC0001310 + (100%) + (100%)
Betalactone‐NRPS‐Type 1 PKS Lomaiviticin BGC0000240 − + (3%)
Other PKS‐Type 1 PKS Roseoflavin BGC0000927 + (100%) −
Sanglifehrin A BGC0001042 − + (4%)
Unknown  + (1 cluster) + (1 cluster)
Trans‐AT PKS Dorrigocin/Migrastatin BGC0000177 + (100%) −
Siderophore Desferrioxamine B BGC0000941 + (80%) + (80%)
Unknown  + (2 clusters) + (2 clusters)
Terpene Hopene BGC0000663 + (61%) + (69%)
Isorenieratene BGC0000664 + (71%) −
Salinomycin BGC0000144 − + (6%)
Unknown  − + (1 cluster)
Thiopeptide‐Terpene Siomycin BGC0000611 + (100%) + (100%)
Total   45 clusters 29 clusters
aMIBiG refers to “Minimum Information about a Biosynthetic Gene cluster” in the antiSMASH 3.0 (Weber et al., 2015). bThe	presence	(+)	or	absence	(−)	
of each gene cluster is determined, while the value indicated in the parenthesis is the similarity percentage to the known cluster or the number of 
cluster found. 
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Although the 16S rRNA gene sequence similarity of TM32 and 
DSM 40032T was 99.23%, this percentage is insufficient to deter‐
mine the difference in genomic species. Therefore, the average 
nucleotide identity values (ANIb and OrthoANIu) between the ge‐
nomes of TM32 and DSM 40032T were computed, whereas ANIb 
and OrthoANIu were 96.80% and 97.14%, respectively. Besides, 
DNA–DNA relatedness value between the two genomes evalu‐
ated by in silico DDH was 75.40%. Following the recent standards 
for using the genome data in the taxonomy of prokaryotes pro‐
posed by Chun et al. (2018), TM32 belongs to the same species 
with DSM 40032T. However, the apparent differences in bioac‐
tivities and genotypes of both strains would be sufficient to pro‐
pose TM32 as a new subspecies of S. sioyaensis, in which a set of 
polyphasic approaches should be performed further to complete 
the taxonomy of TM32.
We believe that our proposing new strain of Streptomyces TM32 
with its potentials to form thermotolerant antibiotics and genome 
insights could be a challenging cell factory that advances various 
biotechnological applications, for instance, novel drug discovery 
to defeat AMR crisis and green technology to optimize organic 
agriculture.
ACKNOWLEDG MENTS
The authors acknowledge the research grants from the National 
Research Council of Thailand (NRCT Grant: R2560B070) and the 
Center of Excellence on Biodiversity – Office of Higher Education 
Commission (BDC‐PG2‐159010). We also thank Dr. Worarat 
Kruasuwan (BIOTEC – National Science and Technology Development 
Agency, Pathum Thani, Thailand) and Mr. Thanarat Salahong (Chiang 
Mai University) for their assistance in the gene annotation analysis. 
WTS and RS have financial support from the Engineering and Physical 
Sciences Research Council of the UK (EPSRC Grant: EP/K038885/1).
CONFLIC T OF INTERE S TS
The authors declare not to have any conflict of interest.
AUTHOR CONTRIBUTIONS
NN provided the bacteria, performed bioactivity tests, and prepared 
the manuscript. SL and WTS gave advices regarding the work. RS 
supervised the work, wrote and edited the manuscript.
E THIC S S TATEMENT
None required.
DATA ACCE SSIBILIT Y
These whole genome shotgun projects have been deposited at DDBJ/
ENA/GenBank under the accessions SDIF00000000 (BioProject: 
PRJNA516206) and SDIG00000000 (BioProject: PRJNA516236) for 
Streptomyces sioyaensis DSM 40032T and Streptomyces sp. TM32, re‐
spectively. The versions described in this paper are SDIF01000000 
and SDIG01000000, accordingly.
ORCID
Rungroch Sungthong  https://orcid.org/0000‐0002‐5052‐2611 
R E FE R E N C E S
Alvin, A., Miller, K. I., & Neilan, B. A. (2014). Exploring the potential of 
endophytes from medicinal plants as sources of antimycobacterial 
compounds. Microbiological Research, 169, 483–495. https://doi.
org/10.1016/j.micres.2013.12.009
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. 
S., … Pevzner, P. A. (2012). SPAdes: A new genome assembly algorithm 
and its applications to single‐cell sequencing. Journal of Computational 
Biology, 19, 455–477. https://doi.org/10.1089/cmb.2012.0021
Bentley, S. D., Chater, K. F., Cerdeño‐Tárraga, A.‐M., Challis, G. L., 
Thomson, N. R., James, K. D., … Hopwood, D. A. (2002). Complete 
genome sequence of the model actinomycete Streptomyces coelicolor 
A3(2). Nature, 417, 141–147. https://doi.org/10.1038/417141a
Chun, J., Oren, A., Ventosa, A., Christensen, H., Arahal, D. R., da Costa, 
M. S., … Trujillo, M. E. (2018). Proposed minimal standards for the 
use of genome data for the taxonomy of prokaryotes. International 
Journal of Systematic and Evolutionary Microbiology, 68, 461–466. 
https://doi.org/10.1099/ijsem.0.002516
Fiorentino, A., Di Cesare, A., Eckert, E. M., Rizzo, L., Fontaneto, D., Yang, 
Y., & Corno, G. (2019). Impact of industrial wastewater on the dy‐
namics of antibiotic resistance genes in a full‐scale urban wastewater 
treatment plant. Science of the Total Environment, 646, 1204–1210. 
https://doi.org/10.1016/j.scitotenv.2018.07.370
Gartel, A. L. (2013). Thiazole antibiotics siomycin A and thiostrepton in‐
hibit the transcriptional activity of FOXM1. Frontiers in Oncology, 3. 
https://doi.org/10.3389/fonc.2013.00150
Gurevich, A., Saveliev, V., Vyahhi, N., & Tesler, G. (2013). QUAST: Quality 
assessment tool for genome assemblies. Bioinformatics, 29, 1072–
1075. https://doi.org/10.1093/bioinformatics/btt086
Meier‐Kolthoff, J. P., Auch, A. F., Klenk, H.‐P., & Göker, M. (2013). Genome 
sequence‐based species delimitation with confidence intervals and 
improved distance functions. BMC Bioinformatics, 14, 60. https://doi.
org/10.1186/1471‐2105‐14‐60
Nakaew, N., Rangjaroen, C., & Sungthong, R. (2015). Utilization of rhizo‐
spheric Streptomyces for biological control of Rigidoporus sp. causing 
white root disease in rubber tree. European Journal of Plant Pathology, 
142, 93–105. https://doi.org/10.1007/s10658‐015‐0592‐0
Nakaew, N., & Sungthong, R. (2018). Seed phytochemicals shape the 
community structures of cultivable actinobacteria‐inhabiting plant 
interiors of Thai pigmented rice. MicrobiologyOpen, 7(4), e00591. 
https://doi.org/10.1002/mbo3.591
Nakaew, N., Sungthong, R., Ortega‐Calvo, J. J., & Lumyong, S. (2012). 
Antibiotic activity and anticancer potential of a new Nonomuraea 
sp. strain PT708 originated from Thai cave soil. In A. Mendez‐Vilas 
(Ed.), Microbes in applied research: Current advances and challenges 
(pp. 474–780). Singapore: World Scientific Publishing. https://doi.
org/10.1142/9789814405041_0096
Piddock, L. J. (2012). The crisis of no new antibiotics—What is the way 
forward? The Lancet Infectious Diseases, 12, 249–253. https://doi.
org/10.1016/S1473‐3099(11)70316‐4
Richter, M., Rosselló‐Móra, R., Oliver Glöckner, F., & Peplies, J. (2015). 
JSpeciesWS: A web server for prokaryotic species circumscription 
based on pairwise genome comparison. Bioinformatics, 32, 929–931. 
https://doi.org/10.1093/bioinformatics/btv681
     |  7 of 7NAKAEW Et Al.
Rodriguez‐Mozaz, S., Chamorro, S., Marti, E., Huerta, B., Gros, M., 
Sànchez‐Melsió, A., … Balcázar, J. L. (2015). Occurrence of antibiot‐
ics and antibiotic resistance genes in hospital and urban wastewaters 
and their impact on the receiving river. Water Research, 69, 234–242. 
https://doi.org/10.1016/j.watres.2014.11.021
Seemann, T. (2014). Prokka: Rapid prokaryotic genome annota‐
tion. Bioinformatics, 30, 2068–2069. https://doi.org/10.1093/
bioinformatics/btu153
Seng, R., Kitti, T., Thummeepak, R., Kongthai, P., Leungtongkam, U., 
Wannalerdsakun, S., & Sitthisak, S. (2017). Biofilm formation of 
methicillin‐resistant coagulase negative staphylococci (MR‐CoNS) 
isolated from community and hospital environments. PLoS ONE, 12, 
e0184172. https://doi.org/10.1371/journal.pone.0184172
Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013). The future of antibi‐
otics and resistance. New England Journal of Medicine, 368, 299–302. 
https://doi.org/10.1056/NEJMp1215093
Strobel, G., & Daisy, B. (2003). Bioprospecting for microbial endophytes 
and their natural products. Microbiology and Molecular Biology 
Reviews, 67, 491–502. https://doi.org/10.1128/MMBR.67.4.491‐ 
502.2003
Tiwari, K., & Gupta, R. K. (2012). Rare actinomycetes: A potential store‐
house for novel antibiotics. Critical Reviews in Biotechnology, 32, 108–
132. https://doi.org/10.3109/07388551.2011.562482
Tori, K., Tokura, K., Yoshimura, Y., Okabe, K., Otsuka, H., Inagaki, 
F., & Miyazawa, T. (1979). 1H NMR spectral evidence for the 
structure and conformation of peptide antibiotic siomycin‐A. The 
Journal of Antibiotics, 32, 1072–1077. https://doi.org/10.7164/
antibiotics.32.1072
Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and 
threats. Pharmacy and Therapeutics, 40, 277.
Weber, T., Blin, K., Duddela, S., Krug, D., Kim, H. U., Bruccoleri, R., … 
Medema, M. H. (2015). antiSMASH 3.0–A comprehensive resource 
for the genome mining of biosynthetic gene clusters. Nucleic Acids 
Research, 43, W237–W243. https://doi.org/10.1093/nar/gkv437
Yoon, S. H., Ha, S. M., Lim, J. M., Kwon, S. J., & Chun, J. (2017). A large‐
scale evaluation of algorithms to calculate average nucleotide 
identity. Antonie van Leeuwenhoek, 110, 1281–1286. https://doi.
org/10.1007/s10482‐017‐0844‐4.
How to cite this article: Nakaew N, Lumyong S, Sloan WT, 
Sungthong R. Bioactivities and genome insights of a 
thermotolerant antibiotics‐producing Streptomyces sp. TM32 
reveal its potentials for novel drug discovery. 
MicrobiologyOpen. 2019;e842. https://doi.org/10.1002/
mbo3.842
